Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-26 @ 4:08 AM
Study NCT ID:
NCT07001618
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-07-23
First Post:
2025-05-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2030-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-09
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-23
First Submit QC Date:
None
Study First Post Date:
2025-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-18
Last Update Post Date:
2025-07-23
Last Update Post Date Type:
ACTUAL